Unique ID issued by UMIN | UMIN000019966 |
---|---|
Receipt number | R000023047 |
Scientific Title | Efficacy and safety of valproic acid in patients with postviral olfactory dysfunction |
Date of disclosure of the study information | 2016/01/01 |
Last modified on | 2022/05/25 13:43:39 |
Efficacy and safety of valproic acid in patients with postviral olfactory dysfunction
Valproic acid treatment of olfactory dysfunction
Efficacy and safety of valproic acid in patients with postviral olfactory dysfunction
Valproic acid treatment of olfactory dysfunction
Japan |
postviral olfactory dysfunction
Oto-rhino-laryngology |
Others
NO
To evaluate efficacy and safety of valproic acid in patients with postviral olfactory dysfunction
Safety,Efficacy
Exploratory
Others
Phase II
changes of average recognition threshold scores measured by T and T olfactometer before and after treatment
changes of scores before and after treatment (visual analog scale and 5 grading scale of subjective symptoms, score measured by the odor stick identification test for Japanese, and average detection threshold scores measured by T and T olfactometer)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
valproic acid Tab (200mg tablet), Sig: 1
tablet po BID for 24 weeks
20 | years-old | <= |
65 | years-old | > |
Male and Female
1) Patients are diagnosed to be a postviral olfactory dysfunction
2) Male patients of 20 or older and younger than 80 at the time of obtaining their consents, and Postmenopausal female patients younger than 65
3) Patients who understand the substances of this Trial and can consent in writing
Exclusion Criteria concerning Diagnosis
1)Patients taking Carbapenem,Barbituric acid,phenytoin, Carbamazepine, ethosuximide, amitriptyline, clobazam, lamotrigine, salicylic acid, Benzodiazepine, warfarin, erythromycin, cimetidine, clonazepam)
2) Patients having a history of serious drug allergies
3) Patients with severe depression, suicidal thinking or suicide attempt or past history of any of these diseases
4) Patients with liver dysfunction
5) Patients with renal dysfunction
6) Female patients having fertility
7) Patients with urea cycle abnormality
8) Patients with past history of an encephalopathy or a coma caused by unknown
9) Patients having a family member with urea cycle abnormality or who experience infant death
10) Patients with subjective olfactory loss before onset of postviral olfactory dysfunction
11) Patients who are otherwise judged unfit as a subject for this trial by a principal investigator or investigators participating in this trial
15
1st name | Hirotaka |
Middle name | |
Last name | Kikuoka |
Shiga university of Medical Science
otorhinolaryngology
520-2153
Seta Tsukinowa-cho, Otsu City,Shiga,JAPAN
077-548-2261
takao971@belle.shiga-med.ac.jp
1st name | Takao |
Middle name | |
Last name | Ogawa |
Shiga university of Medical Science
otorhinolaryngology
520-2153
Seta Tsukinowa-cho, Otsu City,Shiga,JAPAN
077-548-2261
takao971@belle.shiga-med.ac.jp
Shiga university of Medical Science
Department of otorhinolaryngology,
Shiga university of Medical Science
Other
shiga university of medical science
Seta Tsukinowa-cho, Otsu City,Shiga,JAPAN
077-548-3576
hqrec@belle.shiga-med.ac.jp
NO
2016 | Year | 01 | Month | 01 | Day |
Unpublished
Completed
2015 | Year | 11 | Month | 26 | Day |
2015 | Year | 10 | Month | 09 | Day |
2016 | Year | 01 | Month | 01 | Day |
2018 | Year | 08 | Month | 31 | Day |
2018 | Year | 08 | Month | 31 | Day |
2018 | Year | 08 | Month | 31 | Day |
2015 | Year | 11 | Month | 27 | Day |
2022 | Year | 05 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023047